MedTrace Logo

The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm

NCT04602676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-04-20

No results posted yet for this study

Summary

This is a randomized crossover study, where clinicians will be randomized to periods where they will use a rehydration calculator application with or without the Diarrheal Etiology Prediction (DEP) algorithm. The crossover will include a washout period to reduce carryover effect. The study will be conducted over a 9-week period. The Investigators will use a random number generator to randomize clinicians to DEP (use of the etiology calculator) or control arm (use of a previously-tested rehydration calculator) within site for the first 4 weeks. After the first 4 weeks, there will be 1-week washout period without decision support, after which each clinician will cross-over to the other arm for the next 4 weeks.

The Investigators will enroll diarrhea-treating clinicians who treat children presenting with acute diarrhea at sites in Bangladesh and Mali. Utah investigators will only analyze de-identified data provided by our collaborators in Bangladesh and Mali.

Conditions

  • Diarrhea Infectious
  • Algorithms
  • Decision Support Systems, Clinical
  • Clinical Decision-Making

Interventions

DIAGNOSTIC_TEST

Rehydration calculator application with DEP algorithm

4 week period where clinicians will use a rehydration calculator application with the DEP algorithm followed by a 1 week washout period.

DIAGNOSTIC_TEST

Rehydration calculator application

4 week period where clinicians will use a rehydration calculator application without the DEP algorithm followed by a 1 week washout period.

Sponsors & Collaborators

Principal Investigators

  • Daniel Leung, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2021-03-05
Completion
2021-03-05

Countries

  • Bangladesh
  • Mali

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04602676 on ClinicalTrials.gov